Lower mRNA levels of SSTR2 were expressed in the metastases from prostate cancers than in primary prostate cancers, meanwhile, decreased SSTR2 could predict poor prognosis of prostate cancer [35]. The gene discussed is SSTR2; the disease is prostate cancer.